dr. julie gralow discusses the antibody drug conjugate t-dm1 for breast cancer
Published 11 years ago • 281 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:13
dr. julie gralow discusses t-dm1-induced thrombocytopenia
-
1:06
dr. edith perez on the antibody-drug conjugate t-dm1
-
2:01
dr. gralow on the use of bisphosphonates in early-stage breast cancer
-
2:11
dr. julie gralow on treating breast cancer bone metastases
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
1:27
dr. julie gralow on the importance of genetic testing for breast cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
58:27
linking cancer metabolism to neurodegeneration
-
47:48
liquid biopsies to guide breast cancer therapies
-
0:57
dr. louis weiner on the t-dm1 mechanism of action in her2-positive breast cancer
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
1:52
dr. mark pegram discusses earlier treatment with t-dm1
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
1:38
dr. hart on antibody-drug conjugates in her2 breast cancer
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
7:42
julie r. gralow, md: new endocrine therapy for metastatic breast cancer
-
1:04
dr. perez on t-dm1 and the marianne trial
-
1:56
dr. gralow on future research into bisphosphonates in breast cancer
-
4:13
julie gralow, md, offers opinion on immunotherapy treatment trends in the management of tnbc